Management and Board

Dr. Stephan Rietiker, a trained physician qualified to practice medicine both, in Switzerland and the United States, began his career as a physician in Switzerland. He has since gone on to establish himself as an acknowledged expert and leader in healthcare and technology. His executive positions with various global pharmaceutical and medical technology companies including Roche, Boehringer Mannheim, Schering Plough, Covance, Centerpulse and LifeWatch have earned him a strong reputation as a rounded and successful manager and turnaround specialist with extensive experience in the U.S. business world. Following a turnaround of LifeWatch and a successful sale of the company to BioTelemetry Inc., Dr. Rietiker joined the Board of BioTelemetry where he vigorously supported the acquisition of BioTelemetry Inc. by Philips for USD 2.8 B in 2021. In 2022, he incorporated EpiLunar Partners AG based in Zug, Switzerland, to invest in and develop marketable breakthrough solutions in the digital health space. Dr. Rietiker was elected to the MetrioPharm AG Board of Directors for a three-year term at the Extraordinary General Meeting held on April 17, 2025.